18F-FDG texture analysis predicts the pathological Fuhrman nuclear grade of clear cell renal cell carcinoma

1.

Siegel RL, Miller KD, Fuchs HE, Jemal A(2021)Cancer statistics. CA Cancer J Clin. 71(1):7–33. https://doi.org/10.3322/caac.21654

2.

Saad AM, Gad MM, Al-Husseini MJ, Ruhban IA, Sonbol MB, Ho TH(2019)Trends in renal-cell carcinoma incidence and mortality in the United States in the last 2 decades: a SEER-based study. Clin Genitourin Cancer. 17(1):46–57. e5. https://doi.org/10.1016/j.clgc.2018.10.002

3.

Kim H, Inomoto C, Uchida T, Furuya H, Komiyama T, Kajiwara H, Kobayashi H, Nakamura N, Miyajima A(2018)Verification of the international society of urological pathology recommendations in Japanese patients with clear cell renal cell carcinoma. Int J Oncol. 52(4):1139–1148. https://doi.org/10.3892/ijo.2018.4294

4.

Cao C, Bi X, Liang J, Li L, Zhang H, Xiao Z, Xiao Z, Tian J, Wang D, Guan K, Li C, Ma J, Zheng S, Shou J(2019)Long-term survival and prognostic factors for locally advanced renal cell carcinoma with renal vein tumor thrombus. BMC Cancer. 19(1):144. https://doi.org/10.1186/s12885-019-5359-0

5.

Sameh WM, Hashad MM, Eid AA, Abou Yousif TA, Atta MA(2012)Recurrence pattern in patients with locally advanced renal cell carcinoma: the implications of clinicopathological variables. Arab J Urol.10(2):131–137. https://doi.org/10.1016/j.aju.2011.12.007

6.

Becker A, Hickmann D, Hansen J, Meyer C, Rink M, Schmid M, Eichelberg C, Strini K, Chromecki T, Jesche J, Regier M, Randazzo M, Tilki D, Ahyai S, Dahlem R, Fisch M, Zigeuner R, Chun FK(2016)Critical analysis of a simplified Fuhrman grading scheme for prediction of cancer specific mortality in patients with clear cell renal cell carcinoma--impact on prognosis. Eur J Surg Oncol. 42(3):419–425. https://doi.org/10.1016/j.ejso.2015.09.023

7.

Donat SM, Diaz M, Bishoff JT, Coleman JA, Dahm P, Derweesh IH, Herrell SD 3rd, Hilton S, Jonasch E, Lin DW, Reuter VE, Chang SS(2013)Follow-up for clinically localized renal neoplasms: AUA Guideline. J Urol. 190(2):407–416. https://doi.org/10.1016/j.juro.2013.04.121

8.

Escudier B, Porta C, Schmidinger M, Algaba F, Patard JJ, Khoo V, Eisen T, Horwich A(2015)Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [published correction appears in Ann Oncol. 26 Suppl 5: v174–7]. Ann Oncol. 2014;25 Suppl 3: iii49-iii56. https://doi.org/10.1093/annonc/mdu259

9.

Ljungberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L, Merseburger AS, Mulders P, Powles T, Staehler M, Volpe A, Bex A(2015)EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol. 67(5):913–924. https://doi.org/10.1016/j.eururo.2015.01.005

10.

Nakajima R, Nozaki S, Kondo T, Nagashima Y, Abe K, Sakai S(2017)Evaluation of renal cell carcinoma histological subtype and fuhrman grade using 18F-fluorodeoxyglucose-positron emission tomography/computed tomography. Eur Radiol. 27(11):4866–4873. https://doi.org/10.1007/s00330-017-4875-z

11.

Polat EC, Otunctemur A, Ozbek E, Besiroglu H, Dursun M, Ozer K, Horsanali MO(2014)Standardized uptake values highly correlate with tumor size and Fuhrman grade in patients with clear cell renal cell carcinoma. Asian Pac J Cancer Prev. 15(18):7821–7824. https://doi.org/10.7314/apjcp.2014.15.18.7821

12.

Singh H, Arora G, Nayak B, Sharma A, Singh G, Kumari K, Jana S, Patel C, Pandey AK, Seth A, Kumar R(2020)Semi-quantitative F-18-FDG PET/computed tomography parameters for prediction of grade in patients with renal cell carcinoma and the incremental value of diuretics. Nucl Med Commun. 41(5):485–493. https://doi.org/10.1097/MNM.0000000000001169

13.

Mayerhoefer ME, Materka A, Langs G, Häggström I, Szczypiński P, Gibbs P, Cook G(2020)Introduction to Radiomics. J Nucl Med. 61(4):488–495. https://doi.org/10.2967/jnumed.118.222893

14.

Lubner M.G(2019). Reflections on radiogenomics and oncologic radiomics. Abdom Radiol 44, 1959.

15.

Nakajo M, Jinguji M, Aoki M, Tani A, Sato M, Yoshiura T(2020)The clinical value of texture analysis of dual-time-point 18F-FDG-PET/CT imaging to differentiate between 18F-FDG-avid benign and malignant pulmonary lesions. Eur Radiol. 30(3):1759–1769. https://doi.org/10.1007/s00330-019-06463-7

16.

Weber M, Kessler L, Schaarschmidt B, Fendler WP, Lahner H, Antoch G, Umutlu L, Herrmann K, Rischpler C(2020)Textural analysis of hybrid DOTATOC-PET/MRI and its association with histological grading in patients with liver metastases from neuroendocrine tumors. Nucl Med Commun.41(4):363–369. https://doi.org/10.1097/MNM.0000000000001150

17.

Mu W, Tunali I, Gray JE, Qi J, Schabath MB, Gillies RJ(2020)Radiomics of 18F-FDG PET/CT images predicts clinical benefit of advanced NSCLC patients to checkpoint blockade immunotherapy. Eur J Nucl Med Mol Imaging. 47(5):1168–1182. https://doi.org/10.1007/s00259-019-04625-9

18.

DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 44(3):837-845.

CAS  Article  Google Scholar 

19.

Takahashi M, Kume H, Koyama K, Nakagawa T, Fujimura T, Morikawa T, Fukayama M, Homma Y, Ohtomo K, Momose T(2015)Preoperative evaluation of renal cell carcinoma by using 18F-FDG PET/CT. Clin Nucl Med. 40(12):936–940. https://doi.org/10.1097/RLU.0000000000000875

20.

Boktor RR, Walker G, Stacey R, Gledhill S, Pitman AG(2013)Reference range for intrapatient variability in blood-pool and liver SUV for 18F-FDG PET. J Nucl Med. 54(5):677–682. https://doi.org/10.2967/jnumed.112.108530

21.

Noda Y, Kanematsu M, Goshima S, Suzui N, Hirose Y, Matsunaga K, Nishibori H, Kondo H, Watanabe H, Kawada H, Kawai N, Tanahashi Y, Bae KT(2015)18-F fluorodeoxyglucose uptake in positron emission tomography as a pathological grade predictor for renal clear cell carcinomas. Eur Radiol. 25(10):3009–3016. https://doi.org/10.1007/s00330-015-3687-2

22.

Goyal A, Razik A, Kandasamy D, Seth A, Das P, Ganeshan B, Sharma R(2019)Role of MR texture analysis in histological subtyping and grading of renal cell carcinoma: a preliminary study. AbdomRadiol (NY). 44(10):3336–3349. https://doi.org/10.1007/s00261-019-02122-z

23.

Kocak B, Durmaz ES, Ates E, Kaya OK, Kilickesmez O(2019)Unenhanced CT texture analysis of clear cell cenal cell carcinomas: a machine learning-based study for predicting histopathologic nuclear grade [published online ahead of print, 2019 Apr 11]. AJR Am J Roentgenol. W1-W8. https://doi.org/10.2214/AJR.18.20742

24.

Sun J, Pan L, Zha T, Xing W, Chen J, Duan S(2020)The role of MRI texture analysis based on susceptibility-weighted imaging in predicting Fuhrman grade of clear cell renal cell carcinoma. Acta Radiol. 31:284185120951964. https://doi.org/10.1177/0284185120951964.

25.

Deng Y, Soule E, Samuel A, Shah S, Cui E, Asare-Sawiri M, Sundaram C, Lall C, Sandrasegaran K(2019)CT texture analysis in the differentiation of major renal cell carcinoma subtypes and correlation with Fuhrman grade. Eur Radiol. 29(12):6922–6929. https://doi.org/10.1007/s00330-019-06260-2

26.

Nazari M, Shiri I, Hajianfar G, Oveisi N, Abdollahi H, Deevband MR, Oveisi M, Zaidi H(2020)Noninvasive Fuhrman grading of clear cell renal cell carcinoma using computed tomography radiomic features and machine learning. Radiol Med. 125(8):754–762. https://doi.org/10.1007/s11547-020-01169-z

27.

Bhandari A, Ibrahim M, Sharma C, Liong R, Gustafson S, Prior M (2021) CT-based radiomics for differentiating renal tumours: a systematic review. Abdom Radiol 46, 2052–2063. https://doi.org/10.1007/s00261-020-02832-9

Article  Google Scholar 

28.

Bianconi F, Palumbo I, Fravolini ML, Chiari R, Minestrini M, Brunese L, Palumbo B(2019)Texture analysis on [18F]FDG PET/CT in non-small-cell lung cancer: correlations between PET features, CT features, and histological types. Mol Imaging Biol.21(6):1200–1209. https://doi.org/10.1007/s11307-019-01336-3

29.

Nakajo M, Jinguji M, Shinaji T, Nakajo M, Aoki M, Tani A, Sato M, Yoshiura T(2018)Texture analysis of 18F-FDG PET/CT for grading thymic epithelial tumours: usefulness of combining SUV and texture parameters. Br J Radiol. 91(1083):20170546. https://doi.org/10.1259/bjr.20170546

30.

Ou X, Wang J, Zhou R, Zhu S, Pang F, Zhou Y, Tian R, Ma X(2019)Ability of 18F-FDG PET/CT Radiomic Features to distinguish breast carcinoma from breast lymphoma. Contrast Media Mol Imaging. 4507694. https://doi.org/10.1155/2019/4507694

31.

Wang M, Xu H, Xiao L, Song W, Zhu S, Ma X(2019)Prognostic value of functional parameters of 18F-FDG-PET images in patients with primary renal/adrenal lymphoma. Contrast Media Mol Imaging. 2641627. Published 2019 Jul 25. https://doi.org/10.1155/2019/2641627

32.

Zhu S, Xu H, Shen C, Wang Y, Xu W, Duan S, Chen H, Ou X, Chen L, Ma X(2021) Differential diagnostic ability of 18F-FDG PET/CT radiomics features between renal cell carcinoma and renal lymphoma. Q J Nucl Med Mol Imaging. 65(1):72–78. https://doi.org/10.23736/S1824-4785.19.03137-6

33.

Shiri I, Rahmim A, Ghaffarian P, Geramifar P, Abdollahi H, Bitarafan-Rajabi A.(2017)The impact of image reconstruction settings on 18F-FDG PET radiomic features: multi-scanner phantom and patient studies. Eur Radiol. 27(11):4498–4509. https://doi.org/10.1007/s00330-017-4859-z

34.

Orlhac F, Boughdad S, Philippe C, Stalla-Bourdillon H, Nioche C, Champion L, Soussan M, Frouin F, Frouin V, Buvat I(2018)A postreconstruction harmonization method for multicenter radiomic studies in PET. J Nucl Med. 59(8):1321–1328. https://doi.org/10.2967/jnumed.117.199935

35.

Cook GJR, Lovat E, Siddique M, Goh V, Ferner R, Warbey VS(2017)Characterisation of malignant peripheral nerve sheath tumours in neurofibromatosis-1 using heterogeneity analysis of 18F-FDG PET. Eur J Nucl Med Mol Imaging. 44(11):1845–1852. https://doi.org/10.1007/s00259-017-3733-1

36.

Da-Ano R, Visvikis D, Hatt M(2020)Harmonization strategies for multicenter radiomics investigations. Phys Med Biol. 65(24):24TR02. https://doi.org/10.1088/1361-6560/aba798

37.

Da-Ano R, Lucia F, Masson I, Abgral R, Alfieri J, Rousseau C, Mervoyer A, Reinhold C, Pradier O, Schick U, Visvikis D, Hatt M(2021)A transfer learning approach to facilitate combat-based harmonization of multicentre radiomic features in new datasets. PLoS One. 16(7): e0253653. https://doi.org/10.1371/journal.pone.0253653

留言 (0)

沒有登入
gif